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The Cornea in Sjo¨gren’s Syndrome: An In Vivo
Confocal Study
Edoardo Villani, Daniela Galimberti, Francesco Viola, Chiara Mapelli, and
Roberto Ratiglia
PURPOSE. To analyze the in vivo morphology of corneal cells
and nerves in dry eye associated with primary (SSI) and sec-
ondary (SSII) Sjo¨gren’s syndrome and to study its relationship
with the clinical evaluation.
METHODS. Thirty-five patients with SS and 20 age- and gender-
matched control subjects were studied. Confocal microscopy
was used to investigate corneal thickness, epithelial and stro-
mal cellular density, and subbasal plexus morphology.
RESULTS. Corneal central thickness was 514.74  19.85 m in
the SS group and 550  21.46 m in the control group (P 
0.0001, t-test); stromal central thickness was 456.62  18.05
m in the SS group and 487.35  20.40 m in the control
group (P  0.0001). The density of the superficial epithelial
cells in the SSI and SSII groups was 965.40  96.00 and
999.80  115.67 cells/mm2, respectively, and 1488.55 
133.74 cells/mm2 in the control group (P  0.001, ANOVA).
The number of subbasal nerves was 3.34  0.76 in the SS
group and 5.10  0.79 in the control group (P  0.0001,
t-test). The average grade of nerve tortuosity was 2.62  0.94
in the SS group and 1.20  0.70 in the control group (P 
0.0001). Statistically significant correlations were found be-
tween clinical data and confocal microscopy data.
CONCLUSIONS. Corneal thickness, cells, and nerves show mor-
phologic changes in patients with dry eye associated with SS.
The in vivo confocal study of these alterations may be impor-
tant in better understanding the complexity of the ocular
surface morphofunctional unit and the potentials of therapeu-
tic approaches for the control of the phlogistic process and
neuroprotection. (Invest Ophthalmol Vis Sci. 2007;48:
2017–2022) DOI:10.1167/iovs.06-1129
Sjo¨gren’s syndrome (SS) is a chronic inflammatory diseasewith an autoimmune basis. One of its main clinical mani-
festations is keratoconjunctivitis sicca (KCS). In primary SS
(SSI), the presence of specific antibodies and signs of the
infiltration of mononuclear cells in the exocrine glands accom-
pany reduced tear and saliva secretion. In secondary SS (SSII),
the typical symptoms of the primary form are coupled by
another well-defined autoimmune disorder (e.g., rheumatoid
arthritis, SLE [systemic lupus erythematosus], scleroderma).1–3
For many years, KCS was considered to be the result of a
reduced secretion of the aqueous component in tears. Today,
the ocular surface is considered to be a morphofunctional unit
comprising lachrymal film, cornea, limbus, conjunctiva, muco-
epidermal junction, accessory lachrymal glands, Meibomian
glands, principal lachrymal gland, and nervous plexus. The
new interpretation affirms the concept that the alteration of
one of the individual components of the ocular surface system
is followed by pathologic events that extend to the other
structures.4–6
Experimental and clinical studies hypothesized that, in
Sjo¨gren’s syndrome, KCS may be a primitive disease of the
ocular structure, only partly dependent on the deficit of lach-
rymal secretions and therefore susceptible to an evolution of
its own. Alterations in the epithelium surfaces seem too im-
portant to be explained simply by a reduction in lachrymal
secretions for a primitive compromising of the producing
gland. Surface morphologic changes, including the presence of
inflammatory cells and the expression of histocompatibility
antigens (HLA-DR), suggest the participation of epithelial cells
in an important inflammatory and immunologic process in the
pathogenesis of KCS associated with SS. Furthermore, SS im-
plies an alteration in the epithelium and subepithelium inner-
vations, with consequent reduction in corneal sensitivity. An
intact corneal innervation has a trophic effect on the epithelial
cells and is responsible for normal blinking and lachrymal
reflex. Considering that the ocular surface, lachrymal glands,
and nerve endings form a functional unit, the compromising of
one point in this reflex arc could lead to disease of the ocular
surface. It is necessary to study the modifications of the corneal
surface further in depth, for better understanding of the phys-
iopathology of KCS associated with SS, for better differentia-
tion from the degenerative form, and for fine-tuning a more
precise and correct therapeutic treatment.
Traditional methodological clinical and instrumental diag-
nostics are unsatisfactory and limited in the semiological and
functional study of KCS. The use of in vivo confocal micros-
copy permits a completely new approach in the study of the
microscopic morphology of the cornea, offering a resolution
comparable to histologic examination but with an analysis that
is in no way invasive and is quickly executed, safe, and repeat-
able. Furthermore, it allows sequential images to be obtained
of corneal diseases in evolution.
METHODS
Patients
Fifteen of the patients (12 women and 3 men) recruited had SSI
(average age, 52.3  10.3 years; range, 39–73), and 20 patients (14
women and 6 men) had SSII with (average age, 56.5  16.4 years;
range, 30–74). The patients came to our attention at the Ocular
Immunopathology Division after being sent for a visit by the Rheuma-
tology Clinic, where a diagnosis of SSI or SSII was made according to
the criteria proposed by the American-European Consensus Group.7
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The control group (C) was formed by 20 healthy people (13 women
and 7 men; average age, 51.2  18.2 years; range, 27–76), affiliated
with our General Clinic.
Exclusion criteria were the presence of lymphoma, AIDS, sarcoid-
osis, or diabetes mellitus; corneal dystrophy and inflammation; sys-
temic therapy with pharmaceutical drugs with known corneal toxicity;
topical therapy with antiglaucoma drugs, steroids, or NSAIDs; the use
of contact lenses; and previous interventions of ophthalmic surgery.
Each subject had both eyes examined, and the data from the eye
obtaining the highest score in the Van Bijsterveld test with fluorescein
were used for statistical analysis. In the case of subjects who had the
same parameters in both eyes, the selection criteria were on the order
of minor corneal sensitivity, evaluated using the Cochet-Bonnet esthe-
siometer and the lowest result in the Schirmer I test.
All the participants in the study gave informed consent, compiled
in accordance with the Italian laws regarding privacy. The study was
performed in compliance with the tenets of the Declaration of Hel-
sinki.
Clinical Evaluation
A careful case history was compiled for each participant, and each
person completed a questionnaire (Ocular Surface Disease Index;
OSDI)8 for a standardized evaluation of the symptomatology of dry eye.
Besides considering the frequency of dry eye symptoms, the question-
naire attempts to rate their intensity by investigating their ability to
interfere with the participant’s daily activities.
The participants in the study underwent an ophthalmic examina-
tion that included biomicroscopic examination of the ocular adnexa
and anterior segment, evaluation of corneal sensitivity by using the
Cochet-Bonnet nylon-thread esthesiometer, a Schirmer I test under
topical anesthesia, staining with sodium fluorescein 1% collyrium (eval-
uated using the van Bijsterveld method), measurement of the breakup
time of the lachrymal film (BUT), and measurement of the IOP with a
Goldmann applanation tonometer.
Confocal Microscopy
Image Acquisition. The confocal microscopic examination
(Confoscan 2.0; Nidek Technologies, Vigonza, Italy) was performed at
the level of the corneal apex. A drop of anesthetic (oxybuprocaine
chloride 0.4%) was instilled in the lower conjunctival fornix before
examination. During the test, the object lens of the microscope was
covered with gel (hydroxypropilmetil cellulose 0.3%, Carbopol 980
[Noveon Europe, Brussels, Belgium], Dequest 2060S [Solutia, St. Louis,
MO]) and never came in direct contact with the corneal surface. A
drop of antibiotic (ofloxacin 0.3%) was instilled in the lower conjunc-
tival fornix at the end of each examination, and the eye was re-
examined at the slit lamp to verify the integrity of the corneal surface.
A scan of the full thickness of the cornea was automatically per-
formed for each participant; the examination lasted 1.5 to 2.5 minutes.
Each scan recorded 350 images at a distance of 1.5 m, on a z-axis,
from one another. Each scan presented two to four complete passages
from the endothelium to the superficial epithelium. The examinations
were performed with a standard 40 object lens, and each photo
frame included an area of approximately 440  330 m.
Image Analysis. The z-scan curve (a graphic showing the depth
coordinate on the z-axis and the level of reflectivity on the y-axis)9 of
each scan was studied, and the images relative to the superficial and
basal epithelium, the anterior and posterior stroma, and the subbasal
plexus were selected.
All the areas of the z-scan curve where the superficial epithelium
and endothelium peaks were clearly recognizable were considered.
The depth values on the z-axis indicated by the software were used to
determine corneal thickness.
The depth values indicated for the points in the z-scan correspond-
ing to the first stroma photo frame after an image of an endothelium
and the last stroma photo frame before an image referring to the basal
epithelium were used to determine stromal thickness.
The corneal and stromal thicknesses taken into consideration for
statistical analysis were obtained by calculating the mean score of all
values taken from each z-scan curve.
Cell densities of the superficial and basal epithelium and apparent
cell densities of the anterior and posterior stroma were evaluated. The
images previously used to determine stromal thickness were taken into
consideration in the study of the stroma.
In all cases cell density was determined through the manual cell
counting procedure present in the software, taking into consideration
the whole area marked as available for the cell count. The cells partially
contained in the area analyzed were counted only along the right and
lower margins. Results are expressed in cells per square millimeter.
The interobserver variation was calculated by comparing the values
of cell density obtained by a second independent investigator using the
same criteria. The image of the subbasal plexus where the highest
number of nerve fibers recognizable was selected for each scan.
Three parameters were taken into consideration: the number of
nerves, tortuosity, and fiber reflectivity. The last two parameters were
evaluated according to grading (0–4) performed by comparison with
the reference images, according to the method proposed by Oliveira-
Soto and Efron10 (Figs. 1, 2).
Statistical Analysis
All the data are expressed as the average SD. The normal distribution
of variables was verified by the Kolmogorov-Smirnov test. The com-
parison between mean scores was made by using the t-test for each
single sample, specifying the average value of C as the test value in the
SS versus C comparison and the average value of SSI to compare SSII
versus SSI. The level of significance was set at P  0.01.
A two-factor ANOVA (factors: cell layer and disease state) with
multiple comparisons was performed for the cell densities, with the
FIGURE 1. Grading scales for tortuosity provided by Oliveira-Soto and
Efron10: Nerve fibers appear (A) grade 0, almost straight; (B) grade 1,
slightly tortuous; (C) grade 2, moderately tortuous; (D) grade 3, quite
tortuous; or (E) grade 4, very tortuous.
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least significant difference (LSD) post hoc test. The study of correla-
tions between variables was performed by adopting the Spearman
linear correlation index with confidence interval (CI) set at 99%. The
statistical analysis was performed with commercial software (SPSS for
Windows, ver. 9.0; SPSS Sciences, Chicago, IL).
RESULTS
Clinical Data
No relevant alterations were found in any participant after the
confocal microscopic examination. The values relative to the
clinical data (questionnaire, BUT, Schirmer I test, corneal sen-
sitivity, IOP and fluorescein staining) for the SSI, SSII, and
control groups are reported in Table 1.
A statistically significant difference was found between SS
and C in all the parameters studied (P  0.0001, t-test). No
statistically significant difference was found between the SSI
and SSII groups in any of the parameters studied.
Pachymetric Data
Table 2 reports the data relative to corneal and stromal thick-
ness in the SSI, SSII, and control groups. A statistically signifi-
cant difference was found for SS compared to C regarding both
the corneal and stromal thicknesses (P  0.0001, t-test). Con-
versely, none of the two parameters showed a statistically
significant difference between the SSI and SSII groups.
Cellular Density Data
The data relative to cellular density (in cells per square milli-
meter) for the SSI, SSII, and control groups are reported in
Table 3. Comparisons between SS and C revealed a significant
difference in the cell density of the superficial and basal epi-
thelium (P  0.001, LSD) and in the apparent cell density of
the anterior (P  0.001, LSD) and posterior stroma (P  0.01,
LSD). There were no statistically significant differences be-
tween the SSI and SSII groups in any of the parameters ana-
lyzed.
The interobserver variation was 5%, 2%, 8%, and 6% for the
superficial epithelium, basal epithelium, anterior stroma, and
posterior stroma, respectively. A close correlation between the
values obtained by the two investigators (P 0.0001, Pearson)
was found in every cell layer.
Subbasal Plexus Data
Data regarding the number, tortuosity, and reflectivity of nerve
fibers in the SSI, SSII, and control groups are indicated in Table
4. The comparison between SS and C showed a statistically
significant difference in the number of nerve fibers visualized
in the single photo frame (P  0.0001, t-test) and in the
tortuosity of fibers (P 0.0001, t-test). The reflectivity of fibers
did not record any statistically significant difference between
the groups.
FIGURE 2. Grading scales for reflectivity provided by Oliveira-Soto and
Efron10: Nerve fibers are (A) grade 0, almost indistinguishable from
background; (B) grade 1, slightly dimmer than background; (C) grade
2, comparable in reflectivity with background; (D) grade 3, brighter
than background; or (E) grade 4, much higher in reflectivity than
background.
TABLE 1. Clinical Data
Questionnaire BUT Schirmer I Sensivity IOP (A) Fluo
SS 2.52  0.52 3.40  1.64 5.43  2.49 4.90  0.30 14.88  1.05 2.56  0.49
SSI 2.61  96.00 3.00  1.41 4.66  1.63 4.90  0.29 14.66  0.97 2.58  0.41
SSII 2.46  0.53 3.70  1.78 6.00  2.88 4.89  0.32 15.05  1.01 2.55  0.55
C 0.46  0.68 11.55  1.90 12.65  2.06 5.61  0.38 16.60  1.14 0.14  0.18
SS vs. C P  0.0001 P  0.0001 P  0.0001 P  0.0001 P  0.0001 P  0.0001
SSI vs. SSII P  0.278 P  0.076 P  0.007 P  0.828 P  0.15 P  0.734
Data are the mean  SD.
TABLE 2. Corneal and Stromal Thicknesses: Confocal Data
Corneal Thickness Stromal Thickness
SS 514.74  19.85 456.62  18.05
SSI 512.33  19.91 456.00  16.95
SSII 516.55  20.13 457.10  19.26
C 550.00  21.46 487.35  20.40
SS vs. C P  0.0001 P  0.0001
SSI vs. SSII P  0.426 P  0.805
MDD*  15.08 MDD*  8.55
Data are the mean  SD.
* Minimum detectable difference (in micrometers) between SSI
and SSII (  0.01,   0.20, n  15).
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No statistically significant difference was found between
the SSI and SSII groups. In SS group, a close correlation was
noticed between BUT and Schirmer I result, and between
Schirmer I result and fluorescein staining (P  0.0001, Spear-
man). The questionnaire results showed statistically significant
correlations (P  0.01, Spearman) with fluorescein staining,
Schirmer I result, and corneal sensitivity.
As far as the data obtained with the confocal microscope are
concerned, a close correlation was found between superficial
and basal epithelial cellular density and the number of nerve
fibers per photo frame (P  0.001, Spearman) and between
corneal and stromal thickness (P  0.00001, Spearman). Sta-
tistically significant correlations were also recorded between
the following parameter pairs (P  0.01, Spearman): number
of nerves and fiber tortuosity, fiber tortuosity and superficial
epithelial density, superficial epithelial density and anterior
stromal cellular density, and anterior stromal cellular density
and corneal and stromal thickness.
In a comparison of the clinical data and those obtained with
the confocal microscope, statistically significant correlations
were found between questionnaire and nerve fiber tortuosity
(P  0.01, Spearman) and superficial epithelial cellular density
(P  0.0001, Spearman), Schirmer I and number of nerves and
superficial epithelial cellular density (P  0.001, Spearman),
corneal sensitivity and fiber tortuosity (P  0.01, Spearman)
and superficial epithelial cellular density (P 0.01, Spearman),
and fluorescein staining evaluated according to the van Bij-
sterveld method and number of nerves (P  0.01, Spearman)
and nerve tortuosity (P  0.01, Spearman).
DISCUSSION
During the past few years confocal microscopy has been used
more and more frequently in the in vivo study of morphologic
changes of the different corneal components in a wide range of
pathologic processes. The analysis of data in the literature
demonstrates that most studies performed so far in this field
were qualitative studies based on the observation and descrip-
tion of the images of the various corneal structures.
This study offers a systematic evaluation of images, based on
parameters that can be analyzed quantitatively. This approach
permits a comparison between the characteristics and the
extent of the morphologic changes found in sick patients and
in the control group and, above all, highlights the relationships
between clinical signs and morphologic changes in a statisti-
cally significant way.
The findings regarding the association of the questionnaire
results with some of the other clinical parameters on the one
hand and some of the confocal microscopy data on the other
were surprising beyond expectations. The studies performed
by Schein et al.11 and Hay et al.12 emphasized the weak link
between the signs and symptoms that characterize dry eye
syndrome. However, the results in the literature are rather
heterogeneous—especially the characteristics of study sam-
ples and the type of questionnaire adopted. Nichols et al.13
recently reported data similar to those mentioned above, but
using a questionnaire that evaluated symptom frequency ex-
clusively and adopting a coefficient to adapt the data based on
the use of artificial tears. In the same study, Nichols hypothe-
sized that a correlation between signs and symptoms could be
found only in the case of severe dry eye. The statistically
significant correlation between symptoms and the results of
the Schirmer test and between symptoms and rose bengal
staining reported by Bjerrum14 in patients with SSI could be
interpreted in the light of this. However, severe compromising
of nerves and corneal sensitivity may impair the patients’ per-
ception of symptoms, as suggested by the inverted correlation
between symptomatology and lissamine green staining (r 
0.431; P 0.011, Spearman) observed by Adatia et al.15 Even
when comparing the correlations within the individual groups,
the analysis of our data does not permit the rating of variations
of the associations between signs and symptoms based on the
TABLE 3. Cell Densities: Confocal Data
Superficial Epithelium Basal Epithelium Anterior Stroma Posterior Stroma P
SS 985.05  107.56 6197.37  180.34 1263.45  80.83 847.22  46.77
SSI 965.40  96.00 6261.13  168.36 1274.93  32.69 854.33  44.66 0.001#
SSII 999.80  115.67 6149.55  178.03 1255.00  103.47 841.90  48.73 0.001##
C 1485.55  133.74 5861.65  260.40 1098.35  80.43 797.85  41.97 0.001###
P 0.001* 0.001** 0.001*** 0.01****
Data are expressed as cells per square millimeter  SD.
P is by ANOVA.
* SSI vs. C, SSII vs. C; P  0.001, LSD. SSI vs. SSII; P  0.398, LSD.
** SSI vs. C, SSII vs. C; P  0.001, LSD. SSI vs. SSII; P  0.123, LSD.
*** SSI vs. C, SSII vs. C; P  0.001, LSD. SSI vs. SSII; P  0.475, LSD.
**** SSI vs. C, SSII vs. C; P  0.01, LSD. SSI vs. SSII; P  0.423, LSD.
# Superior epithelium. vs. basal epithelium, anterior stroma vs. basal stroma; P  0.001, LSD.
## Superior epithelium vs. basal epithelium, anterior stroma vs. basal stroma; P  0.001, LSD.
### Superior epithelium vs. basal eithelium, anterior stroma vs. basal stroma; P  0.001, LSD.
TABLE 4. Number and Morphology of Subbasal Nerves: Confocal Data
Number of Nerves Tortuosity (Grade, 0–4) Reflectivity (Grade, 0–4)
SS 3.34  0.76 2.62  0.94 2.08  0.78
SSI 3.33  0.81 2.66  0.72 2.13  0.83
SSII 3.35  0.74 2.60  1.09 2.05  0.76
C 5.10  0.79 1.20  0.70 1.85  0.87
SS vs. C P  0.0001 P  0.0001 P  0.083
SSI vs. SSII P  0.938 P  0.727 P  0.705
Data are the mean  SD.
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severity of the pathologic situation. As a matter of fact, the
correlation between the results of the questionnaire and the
various parameters reaches the highest degree of significance
in some cases in the participants in the SSI group (question-
naire with epithelial cellular density), in some cases in the
participants in the SSII group (questionnaire with nerve fibers
tortuosity), and in some cases in the control group (question-
naire with the Schirmer test and fluorescein staining).
The use of the confocal microscope enabled us to highlight
a decrease in central corneal thickness and a significant reduc-
tion in stromal thickness in patients with Sjo¨gren’s syndrome I
and II. The result being in line with those reported by Liu and
Pflugfelder16 and by Tuominen et al.17
The hypothesis is that the corneal thinning noticed in those
patients may be due to natural inflammatory processes. In
particular, the hyperproduction of tumor necrosis factors
TNF- and interleukin IL-I would be responsible for apoptosis
phenomena as well as for an increase in the proteolytic activity
at the stroma level. However, the analysis of the average dif-
ferences in corneal thickness (35.22, t-test) and stromal
thickness (30.46, t-test) between SS and C groups showed
that the reduction of stromal thickness in participants with SS
is not sufficiently marked to justify the whole reduction of
corneal thickness noticed in those patients. Such data, break-
ing away from those found by Tuominen et al.,17 lead to the
hypothesis that in patients with SS, the epithelium has equally
reduced thickness, perhaps due to an increase in the forces
tangentially acting on the ocular surface, given its abnormal
irregularity.
IOP measurements in patients with SS gave lower signifi-
cant results compared with the control group. This result may
depend on the influence of the central corneal thickness on the
results of the Goldmann applanation tonometry. The results of
this study showed an average reduction in central corneal
thickness by 35.22 m (approximately 6%) and a reduced IOP
average of 2.40 mm Hg in the SSISSII group compared with
the C group. Such data are in line with those reported in a
recent meta-analysis by Doughty and Zaman18 and with what
found by Tuonimen et al.,17 who indicated an IOP difference of
2.5 and 2.8 mm Hg, respectively, for a difference in central
corneal thickness of 10% and 6%, respectively.
In the control group, we found apparent anterior and pos-
terior stromal cell densities much higher than the values re-
ported by Patel et al.,19 Popper et al.20 and, for posterior
stromal cells, by Prydal et al.21 Our results are similar to those
reported by Mustonen et al.22 and Benitez del Castillo et al.23
These differences in quantification of the apparent stromal cell
density (expressed in cells per square millimeter) are probably
due to the use of more or less strict criteria for cell identifica-
tion and count and to the different features of the instruments,
lighting, and z-axis resolution in particular (optical sections
include keratocyte nuclei of adjacent layers).
The reduced density of surface epithelial cells in patients
with SS is connected to the corneal surface damage due to
ocular dryness. Indeed, a significant correlation was found
between the density of surface epithelial cells, the fluorescein
staining and the results of tests made to evaluate secretion and
the tear film (Schirmer I and BUT).
The basal epithelial cells and the anterior and posterior
stromal cell components were shown to have increased den-
sity in patients with SS compared with the C group. The
changes in the surface epithelium and the concomitant inflam-
matory processes act as a proliferating stimulus at basal level.
The cellular changes at stromal level could be interpreted as a
result of the inflammatory process that involves the ocular
surface, determining a synchronous increase in the apoptotic
phenomena at stromal level, in the proteolytic activity and
proliferating stimuli.
Furthermore, it is interesting to note that in many patients
with SS the increase in stromal cellular density is accompanied
by “activated keratocytes” (Fig. 3). Hyperreflective stromal cell
nuclei images should be interpreted in a nonsingular way, as
they could be representative of several cases of normal stromal
cells in which the light ray of the confocal microscope strikes
an unusual angle. However, we observed these images more
frequently in patients with SS compared with the C group, as
recently reported by Tuominen et al.17 and Benitez del Castillo
et al.23 It could be assumed that the findings correspond to
keratocytes in a particular state of metabolic activation, in-
duced by proinflammatory cytokines. Those cells would be
able to secrete cell and neural growth factors (NGF), thus
contributing to changes in the stromal and epithelial cells and
nerves.
The number of nerve fibers in the subbasal plexus visible in
the single photo frame was significantly lower in patients with
SS compared with the C group. Tuominen et al.,17 Benitez del
Castillo et al.,23 and Zhang et al.24 have recently performed this
type of evaluation of the density of subbasal nerve fibers in SS
dry eye, with conflicting results. However, it is interesting to
note how the reduced number and increased tortuosity of the
subbasal fibers that this study showed in patients with SS can
be linked to the phenomena of corneal hypoesthesia typical of
this disease and the consequences for tear secretion. The
increased tortuosity of fibers may be due to the simultaneous
action of detrimental phenomena and growth factors (NGF)
secreted over the course of the inflammatory process.
The changes in the subbasal plexus fibers have an important
effect on the complex regulation system of the ocular surface
morphofunctional unit and can compromise various aspects of
it, such as blinking, the tear reflex and trophism of the epithe-
lial cells, thus neatly contributing to the increase of the vicious
cycle of hypotearing–phlogosis–cell-nerve damage.
In conclusion, confocal microscopy permitted us to find
several changes in the corneal morphology of patients affected
by Sjo¨gren’s syndrome. We observed alterations in corneal
thickness, cells, and nerves. On the basis of our results, we
cannot exactly decode all the cause–effect relations among the
different alterations of the ocular surface, which appears as a
complex morphofunctional unit in which each variable inter-
acts in different ways and at different times with many other
variables. Several stages of the vicious cycle that characterizes
the dry eye associated with Sjo¨gren’s syndrome are worth
thorough study, to understand exactly its complex pathogen-
esis and the potential of therapeutic approaches for the control
of the inflammatory process and for neuroprotection.
FIGURE 3. Hyperreflective stromal cells.
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